TCON — TRACON Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00- $0.15m
- -$6.12m
- $12.05m
- 41
- 93
- 14
- 47
Annual balance sheet for TRACON Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 16.4 | 36.1 | 24.1 | 17.4 | 8.56 |
| Prepaid Expenses | |||||
| Total Current Assets | 17.3 | 36.9 | 24.9 | 18.2 | 9.09 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.861 | 0.524 | 1.38 | 1.17 | 0.942 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 18.1 | 37.4 | 26.6 | 19.5 | 10.1 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Current Liabilities | 11.8 | 10.5 | 13.7 | 22.4 | 10.2 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 15.4 | 12.4 | 14.8 | 26.6 | 10.9 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 2.7 | 25.1 | 11.7 | -7.15 | -0.809 |
| Total Liabilities & Shareholders' Equity | 18.1 | 37.4 | 26.6 | 19.5 | 10.1 |
| Total Common Shares Outstanding |